Print

Houston-Based Endothelix Receives FDA Approval for New Cardiovascular Test  
9/13/2007 7:24:58 AM

Houston, Texas (September 6th, 2007) – Endothelix has announced that its non-invasive VENDYS® technology, which utilizes a simple blood pressure cuff and fingertip probes to monitor vascular reactivity, has been approved for commercial use by the U.S. Food & Drug Administration (FDA).
//-->